Chemoinformaics analysis of 10-epi-Acor-3-en-5-one
| Molecular Weight | 218.34 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 218.167 | nRing | 2 |
| Solubility: LogS | -3.968 | nHRing | 0 |
| Solubility: LogP | 3.812 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.61 |
| Synth | 4.846 |
| Natural Product Likeliness | 2.756 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.025 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.535 |
| MDCK | 0.00002 |
| BBB | 0.962 |
| PPB | 0.687795 |
| VDSS | 1.623 |
| FU | 0.20843 |
| CYP1A2-inh | 0.197 |
| CYP1A2-sub | 0.404 |
| CYP2c19-inh | 0.32 |
| CYP2c19-sub | 0.887 |
| CYP2c9-inh | 0.091 |
| CYP2c9-sub | 0.485 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.703 |
| CYP3a4-inh | 0.219 |
| CYP3a4-sub | 0.28 |
| CL | 16.244 |
| T12 | 0.386 |
| hERG | 0.011 |
| Ames | 0.027 |
| ROA | 0.153 |
| SkinSen | 0.649 |
| Carcinogencity | 0.84 |
| EI | 0.962 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.029 |
| Antiviral | Yes |
| Prediction | 0.889672 |